Consumer brand · Sleep and health Acquisition, growth and exit
Novimed: 0.93x in, 3.3x out in under two years
Acquired in July 2021 for 0.93x EBITDA, grown to $2.7M a year, and sold in June 2023 for 3.3x EBITDA, generating $3.5M in ROI.
- EBITDA multiple at acquisition
- 0.93x
- Annual revenue at exit
- $2.7M
- EBITDA multiple at exit
- 3.3x
- ROI generated
- $3.5M
The acquisition
We acquired Novimed in July 2021 for 0.93x EBITDA.
What we did
We grew the brand to $2.7M a year in revenue and prepared it for sale.
The exit
The sale process attracted offers from 5 different parties. We exited in June 2023 at 3.3x EBITDA, generating $3.5M in ROI for the investor.
